Abstract

Hepatic lipase (LIPC) is a key rate-limiting enzyme in lipoprotein catabolism pathways involved in the development of obesity. The C-514T polymorphism in the promoter region is associated with decreased LIPC activity. We performed a case-controlled study (850 obese children and 2119 controls) and evaluated the association between LIPC C-514T polymorphism, obesity and plasma lipid profile in Chinese children and adolescents. Additionally, we conducted a meta-analysis of all results from published studies as well as our own data. A significant association between the polymorphism and obesity is observed in boys (P = 0.042), but not in girls. And we observed a significant relationship of the polymorphism with total cholesterol (TC) and high density lipoprotein cholesterol (HDL-C) independent of obesity in boys. The T allele carriers have higher levels of low density lipoprotein cholesterol (LDL-C) in obese boys, and triglyceride (TG), TC and LDL-C in non-obese girls (all P < 0.05). In the meta-analysis, under dominant model the T allele increased body mass index (BMI) level in boys, while it decreased BMI in girls, and increased the levels of TC both in the overall and subgroups, TG and HDL-C in the overall and boys, and LDL-C in the overall (all P < 0.05). Our results suggest that the T allele might carry an increased risk of obesity in Chinese boys. The meta-analysis suggests that T allele acts as a risk allele for higher BMI levels in male childhood, while it is a protective allele in female childhood. And the polymorphism is associated with the levels of plasma lipids, which may be modulated by obesity and gender.

Highlights

  • The hepatic lipase gene (LIPC) is a member of the lipase gene family, in which protein sequence homology with other lipases is 30–75% [1]

  • Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine

  • We explored the associations between the LIPC C-514T polymorphism, obesity and plasma lipid profiling in a representative sample of Chinese children and adolescents

Read more

Summary

Introduction

The hepatic lipase gene (LIPC) is a member of the lipase gene family, in which protein sequence homology with other lipases is 30–75% [1]. LIPC has been cloned from two human liver cDNA libraries by cross-hybridization with the determined rat cDNA clone [2]. It is a secretory glycoprotein enzyme synthesized predominantly by the liver, and distributed on the surfaces of hepatocytes and sinusoidal endothelium [3]. Since it plays an important role in lipoprotein catabolism pathways [3], LIPC has been implicated in the risk of coronary artery disease, where its effect is dependent on the underlying lipoprotein phenotype or disorder [4]. LIPC was identified as an obesity candidate gene in a mouse model, LIPC deficient mouse can be protected against diet-in-

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.